REVEAL GENOMICS ®, a pioneering Barcelona-based biotech company dedicated to advancing precision oncology, is proud to announce the publication of a groundbreaking study demonstrating the clinical ...

A home urine test demonstrated high sensitivity for detection of aggressive prostate cancer, according to study findings.The ...

The Cytek® Muse® Micro is an affordable cell analyzer that simplifies flow cytometry while enhancing ease-of-use, precision ...

Drilling at ATEX Resources’ (TSXV: ATX) Valeriano copper-gold project in northern Chile returned results as high as 2.21% ...

Bureau Veritas, an inspection, and certification services provider, announced the acquisition of GeoAssay, a specialist in copper analysis.

A major biotech breakthrough is happening in New Orleans. Beken Bio, a biotech startup company that is soon to be based at the ...

Drillhole WMA082-12 Intersected 17.0 Metres at 10.81% U3O8; Including 10.5 Metres at 17.30% U3O8 Drillhole WMA094-02 Intersected 6.5 Metres at ...

AngloGold Ashanti (NYSE:AU) currently holds 35,948,965 shares representing 14.99% of the issued and outstanding shares of G2. G2 currently has cash holdings exceeding C$37 million (unaudited) and is ...

The study demonstrates that PAC-MANN-1 outperforms the widely used CA 19-9 biomarker, offering greater accuracy in detecting all stages of PDAC. The assay is particularly promising for identifying ...

March 17, 2025) - Cascada Silver Corp. (CSE: CSS) ("Cascada") is pleased to announce that final assays from its Phase II ...

That’s why we are excited to present the 3rd Gene Therapy Potency Assay Summit, taking place in Boston from May 28-29, 2025.